SERAPH BIOSCIENCES, INC. — Form D
SERAPH BIOSCIENCES, INC. of DETROIT, MI, a company, filed a Form D exempt-offering notice with the SEC on 2019-01-07. The offering totals $4.2M, of which $1.5M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2019-01-07
- Form: D
- Accession: 0000905729-19-000003
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $4.2M
- Amount sold: $1.5M
- Remaining: $2.7M
- Investors: 15
- Date of first sale: 2018-12-21
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-329796
Issuer
- Name: SERAPH BIOSCIENCES, INC.
- CIK: 0001697736
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2016
- Address: 1001 WOODWARD AVENUE, DETROIT, MI, 48226
- Phone: 313-759-8009
Officers, directors & promoters (18)
| Name | Role | Location |
|---|
| Gregory Auner | Executive Officer | Detroit, MI |
| James Mault | Director | Golden, CO |
| Gary Loveman | Director | Detroit, MI |
| Ahmad Nadeem Ishaque | Director | Detroit, MI |
| Charles Shanley | Director | Detroit, MI |
| Charles Shanley | Executive Officer | Detroit, MI |
| Scott Nadeem Merz | Director | Detroit, MI |
| James Nadeem Shanley | Executive Officer | Detroit, MI |
| Michael Shields | Director | Detroit, MI |
| Richard Nadeem Creager | Director | Detroit, MI |
| Braden Nadeem Robison | Executive Officer | Detroit, MI |
| Scott Merz | Director | Detroit, MI |
| Paul Glantz | Director | Detroit, MI |
| Gregory Auner | Director | Detroit, MI |
| Matthew Cullen | Director | Detroit, MI |
| James Shanley | Executive Officer | Detroit, MI |
| Braden Robison | Executive Officer | Detroit, MI |
| MARK TREXLER | Executive Officer | DETROIT, MI |
Other filings by this issuer (3)
More